QSAM Biosciences, Inc.
A408WA
Recommendation
--
Prev Close
Volume
--
Avg Vol (90D)
Market Cap
--
Dividend & Yield
--
52-Week Range
P/E (TTM)
--
EPS (TTM)
--
| 12/31/2023 | 09/30/2023 | 06/30/2023 | 03/31/2023 | 12/31/2022 | |
|---|---|---|---|---|---|
| Net Income | -4.39M | -5.09M | -5.15M | -5.20M | -5.48M |
| Total Depreciation and Amortization | -- | -- | -- | -- | -- |
| Total Amortization of Deferred Charges | 36.30K | 45.40K | 54.50K | 63.60K | 36.40K |
| Total Other Non-Cash Items | 1.65M | 2.08M | 2.15M | 2.21M | 1.96M |
| Change in Net Operating Assets | -144.20K | 121.50K | 97.50K | 435.20K | 770.10K |
| Cash from Operations | -2.85M | -2.84M | -2.85M | -2.49M | -2.71M |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | -- |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 2.01M | 2.39M | 2.81M | 2.47M | 1.40M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 2.00M | 0.00 | 0.00 | 0.00 | 35.00K |
| Cash from Financing | 4.01M | 2.39M | 2.81M | 2.47M | 1.44M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 1.16M | -452.70K | -39.70K | -20.70K | -1.27M |
